Cargando…

Editorial: Parkinson's disease: cell vulnerability and disease progression

Detalles Bibliográficos
Autores principales:	Blesa, Javier, Lanciego, Jose L., Obeso, Jose A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4569747/ https://www.ncbi.nlm.nih.gov/pubmed/26441555 http://dx.doi.org/10.3389/fnana.2015.00125

Ejemplares similares

Habitual behavior and dopamine cell vulnerability in Parkinson disease
por: Hernández, Ledia F., et al.
Publicado: (2015)

Corrigendum: Habitual Behavior and Dopamine Cell Vulnerability in Parkinson Disease
por: Hernández, Ledia F., et al.
Publicado: (2015)

Past, Present, and Future of the Pathophysiological Model of the Basal Ganglia
por: Obeso, José A., et al.
Publicado: (2011)

Inter-hemispheric asymmetry of nigrostriatal dopaminergic lesion: a possible compensatory mechanism in Parkinson’s disease
por: Blesa, Javier, et al.
Publicado: (2011)

Parkinson’s disease: animal models and dopaminergic cell vulnerability
por: Blesa, Javier, et al.
Publicado: (2014)

Changes in thalamic dopamine innervation in a progressive Parkinson's disease model in monkeys
por: Monje, Mariana H.G., et al.
Publicado: (2019)

Vulnerability of Mesostriatal Dopaminergic Neurons in Parkinson's Disease
por: González-Hernández, Tomás, et al.
Publicado: (2010)

Early Paradoxical Increase of Dopamine: A Neurochemical Study of Olfactory Bulb in Asymptomatic and Symptomatic MPTP Treated Monkeys
por: Pifl, Christian, et al.
Publicado: (2017)

BBB opening with focused ultrasound in nonhuman primates and Parkinson’s disease patients: Targeted AAV vector delivery and PET imaging
por: Blesa, Javier, et al.
Publicado: (2023)

Editorial: Integrative Approach to Parkinson's Disease
por: Kim, Seung-Nam, et al.
Publicado: (2019)

Editorial: Sleep disturbances in Parkinson's disease
por: Salsone, Maria, et al.
Publicado: (2023)

Molecular determinants of selective dopaminergic vulnerability in Parkinson’s disease: an update
por: Brichta, Lars, et al.
Publicado: (2014)

Calbindin content and differential vulnerability of midbrain efferent dopaminergic neurons in macaques
por: Dopeso-Reyes, Iria G., et al.
Publicado: (2014)

Basal Ganglia Circuits: What's Now and Next?
por: Lanciego, Jose L.
Publicado: (2012)

Selective dopaminergic vulnerability in Parkinson’s disease: new insights into the role of DAT
por: Harraz, Maged M.
Publicado: (2023)

Editorial: Sound, Music, and Movement in Parkinson’s Disease
por: Bieńkiewicz, Marta M. N., et al.
Publicado: (2016)

Editorial: The Role of Lipids in the Pathogenesis of Parkinson's Disease
por: Baekelandt, Veerle, et al.
Publicado: (2020)

Editorial: Genetic and Epigenetic Mechanisms of Parkinson's Disease
por: Li, Song, et al.
Publicado: (2022)

Editorial: Protein Degradation Pathways in Parkinson's Disease and Neurodegeneration
por: Volta, Mattia, et al.
Publicado: (2020)

Editorial: The Role of Stem Cells, Epigenetics and MicroRNAs in Parkinson's Disease
por: Hegarty, Shane V., et al.
Publicado: (2020)

Midbrain catecholaminergic neurons co-express α-synuclein and tau in progressive supranuclear palsy
por: Erro Aguirre, María Elena, et al.
Publicado: (2015)

Editorial: Highlights in Alzheimer's and Parkinson's disease
por: Cantone, Mariagiovanna, et al.
Publicado: (2023)

Editorial: Mitochondria and Endoplasmic Reticulum Dysfunction in Parkinson’s Disease
por: Barodia, Sandeep Kumar, et al.
Publicado: (2019)

Editorial: Biomarkers and Pathogenesis of Alpha-Synuclein in Parkinson's Disease
por: Li, Puyu, et al.
Publicado: (2021)

Differential Progression of Regional Hippocampal Atrophy in Aging and Parkinson’s Disease
por: Uribe, Carme, et al.
Publicado: (2018)

Editorial: Non-invasive Brain Stimulation in Neurology and Psychiatry
por: Obeso, Ignacio, et al.
Publicado: (2016)

Editorial: Genetic and molecular diversity in Parkinson's disease
por: Abdul Murad, Nor Azian, et al.
Publicado: (2022)

Editorial: Disease-modifying targets and strategies for Alzheimer's disease and Parkinson's disease
por: Gao, Xiaoya
Publicado: (2023)

MicroRNAs in the epigenetic regulation of disease progression in Parkinson’s disease
por: Selvakumar, Sushmaa Chandralekha, et al.
Publicado: (2022)

Editorial: Experimental and Innovative Approaches to Multi-Target Treatment of Parkinson's and Alzheimer's Diseases
por: Tikhonova, Maria A., et al.
Publicado: (2022)

Rest tremor in Parkinson’s disease: the theta and beta sides of the coin
por: Foffani, Guglielmo, et al.
Publicado: (2020)

SARS-CoV-2 and the risk of Parkinson's disease: facts and fantasy
por: Merello, Marcelo, et al.
Publicado: (2021)

Variants in the SNCA Locus Are Associated With the Progression of Parkinson's Disease
por: Luo, Ningdi, et al.
Publicado: (2019)

Oxidative stress and Parkinson’s disease
por: Blesa, Javier, et al.
Publicado: (2015)

The emerging role of nutrition in Parkinson's disease
por: Seidl, Stacey E., et al.
Publicado: (2014)

Classic and New Animal Models of Parkinson's Disease
por: Blesa, Javier, et al.
Publicado: (2012)

Olfactory Dysfunction Predicts Disease Progression in Parkinson’s Disease: A Longitudinal Study
por: He, Runcheng, et al.
Publicado: (2020)

Biological and Clinical Implications of Comorbidities in Parkinson’s Disease
por: Santiago, Jose A., et al.
Publicado: (2017)

Astroglia in the Vulnerability to and Maintenance of Stress-Mediated Neuropathology and Depression
por: Miguel-Hidalgo, José Javier
Publicado: (2022)

Editorial: Insights into Parkinson's disease and aging related movement disorders
por: Petersen, Robert B., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_uoqmeaq0t10oml4gdpudjuqguf